Atlantic American Corporation (AAME) 10-Year Financial Performance & Capital Metrics

AAME • • Insurance & Managed Care

Financial ServicesLife InsuranceSpecialized Life InsurersFinal Expense & Niche Life Providers

AboutAtlantic American Corporation, through its subsidiaries, provides life and health, and property and casualty insurance products in the United States. The company operates through American Southern and Bankers Fidelity segments. It offers property and casualty insurance products, including business automobile insurance coverage for state governments, local municipalities, and other motor pools and fleets; and inland marine and general liability insurance products. The company also provides surety bond coverage for subdivision construction, school bus contracts, as well as performance and payment bonds. In addition, the company provides individual and group whole life insurance, as well as medicare supplement insurance products; and other accident and health insurance coverages, include various individual and group policies for the payment of standard benefits for the treatment of diagnosed cancer and other critical illnesses, as well as various other policies, such as short-term nursing facility care, accident expense, hospital indemnity, and disability coverages. It markets its products through independent agents and brokers. The company was founded in 1937 and is headquartered in Atlanta, Georgia.Show more

Revenue $188M +0.8%
Combined Ratio 102.8% +2.5%
Net Income -$4M -2395.9%
Return on Equity -4.13% -2426.6%
Medical Cost Ratio 92.37% +2.3%
Operating Margin -2.8% -824.6%
Net Margin -2.27% -2376.9%
ROA -1.1% -2311.2%
Equity / Assets 25.32% -10.0%
Book Value per Share 4.88 -7.1%
Tangible BV/Share 4.76 -9.5%
Debt/Equity 0.38 +10.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.6x book value

✗Weaknesses

✗High loss ratio of 92.4%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y1.24%

5Y-1.03%

3Y-1.93%

TTM11.99%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM173.93%

EPS CAGR

10Y-

5Y-

3Y-

TTM165.35%

ROCE

10Y Avg1.39%

5Y Avg0.86%

3Y Avg-0.33%

Latest-1.37%

Peer Comparison

Final Expense & Niche Life Providers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CIACitizens, Inc.	275.63M	5.48	18.90	1.8%	4.4%	4.82%	11.34%	0.04
AAMEAtlantic American Corporation	61.4M	3.01	-13.09	0.77%	2.45%	4.66%	7.45%	0.38

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	165.94M	166.08M	181.11M	185.55M	198.18M	195.35M	199.55M	187.85M	186.79M	188.23M
Revenue Growth %	-0%	0%	0.09%	0.02%	0.07%	-0.01%	0.02%	-0.06%	-0.01%	0.01%
Medical Costs & Claims+	144.6M	147.99M	160.96M	171.69M	184.7M	166.69M	179.19M	170.17M	168.62M	173.86M
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	21.34M	18.08M	20.15M	13.86M	13.48M	28.66M	20.36M	17.68M	18.17M	14.37M
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	0.11%	-0.15%	0.11%	-0.31%	-0.03%	1.13%	-0.29%	-0.13%	0.03%	-0.21%
Operating Expenses+	15.63M	14.56M	14.8M	14.83M	13.88M	13.16M	15.06M	15.59M	18.73M	19.63M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	1.12M	1.21M	1.44M	987K	996K	980K	1M	890K	652K	366K
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	5.71M	3.52M	5.36M	-971K	-407K	15.5M	5.3M	2.1M	-565K	-5.26M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	0.16%	-0.38%	0.52%	-1.18%	0.58%	39.09%	-0.66%	-0.6%	-1.27%	-8.32%
EBITDA+	6.83M	4.73M	6.79M	16K	589K	16.48M	6.3M	2.99M	87K	-4.9M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	1.43M	1.56M	1.72M	2.04M	2.13M	1.61M	1.39M	1.95M	3.27M	3.42M
Non-Operating Income	-1.43M	-1.56M	-1.72M	-2.04M	-2.13M	-1.61M	-1.39M	-1.95M	-3.27M	-3.42M
Pretax Income+	5.71M	3.52M	5.36M	-971K	-407K	15.5M	5.3M	2.1M	-565K	-5.26M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	1.32M	888K	828K	-267K	-21K	3.33M	1.02M	571K	-394K	-996K
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	4.39M	2.64M	4.53M	-704K	-386K	12.17M	4.28M	1.52M	-171K	-4.27M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.01%	-0.4%	0.72%	-1.16%	0.45%	32.53%	-0.65%	-0.64%	-1.11%	-23.96%
EPS (Diluted)+	0.19	0.11	0.20	-0.03	-0.02	0.56	0.19	0.06	-0.03	-0.23
EPS Growth %	0%	-0.42%	0.82%	-1.17%	0.45%	30.32%	-0.66%	-0.71%	-1.51%	-7.24%
EPS (Basic)	0.19	0.11	0.20	-0.03	-0.02	0.58	0.19	0.06	-0.03	-0.23
Diluted Shares Outstanding	23.09M	23.96M	22.64M	20.28M	20.26M	21.82M	20.4M	20.39M	20.4M	20.4M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	314.6M	318.6M	343.24M	344.27M	377.63M	405.19M	402.29M	367.06M	381.26M	393.43M
Asset Growth %	-0.01%	0.01%	0.08%	0%	0.1%	0.07%	-0.01%	-0.09%	0.04%	0.03%
Total Investment Assets+	229.69M	232.16M	239.7M	241.93M	489.1M	279.31M	542.33M	430.26M	237.07M	221.75M
Long-Term Investments	229.69M	232.16M	239.7M	232.38M	256.63M	274.06M	281.35M	221.53M	228.87M	221.75M
Short-Term Investments	0	0	0	210.39M	232.47M	254.11M	260.99M	208.73M	37.34M	0
Total Current Assets+	15.62M	13.25M	24.55M	12.63M	290.63M	0	328.11M	28.86M	0	35.57M
Cash & Equivalents	254.01M	257.43M	272.06M	12.63M	12.89M	19.32M	24.75M	28.86M	28.3M	35.57M
Receivables	0	0	0	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	26.03M	-330.02M	41.45M	-202M	-110.44M	-50.4M
Goodwill & Intangibles+	2.54M	2.54M	2.54M	2.54M	2.54M	2.54M	2.54M	2.54M	2.54M	2.54M
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	2.54M	2.54M	2.54M	2.54M	2.54M	0	2.54M	2.54M	0	2.54M
PP&E (Net)	-829K	-160K	-593K	-4.18M	258.86M	0	282.14M	3.4M	0	5.22M
Other Assets	-171.64M	-173.54M	-171.06M	-145.21M	-259.18M	-276.6M	-283.89M	-224.93M	-231.41M	-247.19M
Total Liabilities	212.11M	213.09M	230.26M	242.9M	259.23M	260.13M	261M	264.87M	273.99M	293.81M
Total Debt+	33.74M	33.74M	33.74M	33.74M	33.74M	33.74M	33.74M	35.75M	36.76M	37.76M
Net Debt	-220.27M	-223.69M	-238.32M	21.11M	20.84M	14.42M	8.98M	6.88M	8.46M	2.19M
Long-Term Debt	33.74M	33.74M	33.74M	33.74M	33.74M	33.74M	33.74M	35.75M	33.74M	33.74M
Short-Term Debt	0	0	0	0	0	0	1.03M	1.05M	3.02M	4.02M
Total Current Liabilities+	178.37M	179.36M	196.52M	209.16M	49.31M	0	1.75M	2.01M	0	4.02M
Accounts Payable	0	0	0	0	23.59M	0	25.46M	26.47M	0	0
Deferred Revenue	0	0	0	0	314K	0	0	-24.46M	0	0
Other Current Liabilities	-15.03M	-16.68M	-22.34M	-20.12M	25.41M	0	-24.74M	-1.05M	-3.02M	0
Deferred Taxes	-1000K	-1000K	593K	875K	1000K	1000K	1000K	919K	0	0
Other Liabilities	7.79M	9.71M	196.52M	0	0	-35.04M	-33.74M	229.12M	-33.74M	256.05M
Total Equity+	102.49M	105.51M	112.98M	101.37M	118.39M	145.06M	141.29M	102.19M	107.28M	99.61M
Equity Growth %	-0.02%	0.03%	0.07%	-0.1%	0.17%	0.23%	-0.03%	-0.28%	0.05%	-0.07%
Shareholders Equity	102.49M	105.51M	112.98M	101.37M	118.39M	145.06M	141.29M	102.19M	107.28M	99.61M
Minority Interest	0	0	0	0	0	0	0	0	0	0
Retained Earnings	25.44M	27.27M	30.99M	37.21M	36.02M	47.79M	51.26M	51.98M	50.93M	45.85M
Common Stock	22.4M	22.4M	22.4M	22.4M	22.4M	22.4M	22.4M	22.4M	22.4M	22.4M
Accumulated OCI	4.58M	5.83M	9.75M	-7.54M	10.46M	25M	17.69M	-22.15M	-16.12M	-18.71M
Return on Equity (ROE)	0.04%	0.03%	0.04%	-0.01%	-0%	0.09%	0.03%	0.01%	-0%	-0.04%
Return on Assets (ROA)	0.01%	0.01%	0.01%	-0%	-0%	0.03%	0.01%	0%	-0%	-0.01%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.33x	0.32x	0.30x	0.33x	0.28x	0.23x	0.24x	0.35x	0.34x	0.38x
Book Value per Share	4.44	4.40	4.99	5.00	5.84	6.65	6.93	5.01	5.26	4.88
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	2.21M	1.32M	2.63M	4.46M	-1.81M	8.97M	1.09M	6.45M	2.62M	4.8M
Operating CF Growth %	-0.5%	-0.4%	1%	0.69%	-1.41%	5.96%	-0.88%	4.93%	-0.59%	0.83%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	4.39M	2.64M	4.53M	-704K	-386K	12.17M	4.28M	1.52M	-171K	-4.27M
Depreciation & Amortization	1.12M	1.21M	1.44M	987K	996K	980K	1M	890K	652K	366K
Stock-Based Compensation	365K	586K	495K	244K	353K	437K	211K	134K	119K	11K
Deferred Taxes	304K	-2K	-1.36M	-2.24M	-913K	-2.25M	-1.11M	-1.82M	-3.12M	-1.75M
Other Non-Cash Items	-5.99M	-3.69M	-12.85M	3.15M	-13.48M	-2.81M	-7.01M	2.79M	-738K	54K
Working Capital Changes	2.02M	576K	10.38M	3.02M	11.62M	443K	3.72M	2.94M	5.88M	10.38M
Cash from Investing+	-1.2M	-2.23M	10.13M	-14.79M	3.01M	-2.06M	5.3M	-3.43M	-3.37M	2.28M
Capital Expenditures	-322K	-396K	-103K	-281K	-69K	-233K	-107K	-126K	-80K	-225K
Acquisitions	879K	1.84M	-10.23M	14.51M	0	1.83M	-5.41M	3.3M	0	0
Purchase of Investments	-91.68M	-75.07M	-84.55M	-49.55M	-124.03M	-27.49M	-35.29M	-17.01M	0	-13.85M
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0	1000K
Other Investing	-879K	-1.84M	10.23M	-14.51M	0	-1.83M	5.41M	-3.3M	-3.29M	0
Cash from Financing+	-1.76M	-1.45M	-1.47M	-1.59M	-939K	-481K	-954K	1.08M	181K	186K
Dividends Paid	-811K	-807K	-807K	-806K	-802K	-399K	-807K	-807K	-807K	-807K
Share Repurchases	-997K	-698K	-692K	-820K	-71K	-91K	-153K	-108K	-12K	-7K
Stock Issued	47K	51K	32K	36K	0	9K	6K	0	0	0
Debt Issuance (Net)	0	0	0	0	0	0	0	1000K	1000K	1000K
Other Financing	47K	51K	32K	36K	-66K	0	0	0	0	0
Net Change in Cash+	-753K	-2.37M	11.29M	-11.92M	263K	6.43M	5.43M	4.11M	-562K	7.27M
Exchange Rate Effect	0	0	0	0	0	0	0	0	0	0
Cash at Beginning	16.38M	15.62M	13.25M	24.55M	12.63M	12.89M	19.32M	24.75M	28.86M	28.3M
Cash at End	15.62M	13.25M	24.55M	12.63M	12.89M	19.32M	24.75M	28.86M	28.3M	35.57M
Free Cash Flow+	1.89M	920K	2.53M	4.18M	-1.88M	8.74M	981K	6.33M	2.54M	4.58M
FCF Growth %	4.79%	-0.51%	1.75%	0.65%	-1.45%	5.66%	-0.89%	5.45%	-0.6%	0.8%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	0.08	0.04	0.11	0.21	-0.09	0.4	0.05	0.31	0.12	0.22

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	96.56%	97.88%	97.04%	100.52%	100.21%	92.06%	97.34%	98.88%	100.3%	102.8%
Medical Cost Ratio	87.14%	89.11%	88.87%	92.53%	93.2%	85.33%	89.8%	90.59%	90.27%	92.37%
Return on Equity (ROE)	4.25%	2.53%	4.14%	-0.66%	-0.35%	9.24%	2.99%	1.25%	-0.16%	-4.13%
Return on Assets (ROA)	1.39%	0.83%	1.37%	-0.2%	-0.11%	3.11%	1.06%	0.4%	-0.05%	-1.1%
Equity / Assets	32.58%	33.12%	32.92%	29.45%	31.35%	35.8%	35.12%	27.84%	28.14%	25.32%
Book Value / Share	4.44	4.4	4.99	5	5.84	6.65	6.93	5.01	5.26	4.88
Debt / Equity	0.33x	0.32x	0.30x	0.33x	0.28x	0.23x	0.24x	0.35x	0.34x	0.38x
Revenue Growth	-0.23%	0.08%	9.05%	2.45%	6.8%	-1.43%	2.15%	-5.86%	-0.56%	0.77%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Bankers Fidelity	96.38M	99.7M	109.67M	119.12M	123.25M	121.17M	116.23M	115.16M	110.38M	111.04M
Bankers Fidelity Growth	-	3.44%	9.99%	8.62%	3.46%	-1.69%	-4.07%	-0.92%	-4.15%	0.60%
Corporate, Non-Segment	-	-	-	-	-	-	-	-	-	-
Corporate, Non-Segment Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
American Southern	54.51M	53.76M	53.66M	53.81M	58.68M	62.37M	67.98M	70.28M	68.44M	67.69M
American Southern Growth	-	-1.37%	-0.19%	0.27%	9.06%	6.29%	8.99%	3.37%	-2.61%	-1.10%

Frequently Asked Questions

Growth & Financials

Atlantic American Corporation (AAME) grew revenue by 0.8% over the past year. Growth has been modest.

Yes, Atlantic American Corporation (AAME) is profitable, generating $5.1M in net income for fiscal year 2024 (-2.3% net margin).

Dividend & Returns

Yes, Atlantic American Corporation (AAME) pays a dividend with a yield of 0.66%. This makes it attractive for income-focused investors.

Atlantic American Corporation (AAME) has a return on equity (ROE) of -4.1%. Negative ROE indicates the company is unprofitable.

Industry Metrics

Atlantic American Corporation (AAME) has a combined ratio of 102.8%. A ratio above 100% means claims and expenses exceed premiums.

US Stock Screener

...

Atlantic American Corporation (AAME) 10-Year Financial Performance & Capital Metrics

AAME • • Insurance & Managed Care

Financial ServicesLife InsuranceSpecialized Life InsurersFinal Expense & Niche Life Providers

Revenue $188M +0.8%
Combined Ratio 102.8% +2.5%
Net Income -$4M -2395.9%
Return on Equity -4.13% -2426.6%
Medical Cost Ratio 92.37% +2.3%
Operating Margin -2.8% -824.6%
Net Margin -2.27% -2376.9%
ROA -1.1% -2311.2%
Equity / Assets 25.32% -10.0%
Book Value per Share 4.88 -7.1%
Tangible BV/Share 4.76 -9.5%
Debt/Equity 0.38 +10.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.6x book value

✗Weaknesses

✗High loss ratio of 92.4%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y1.24%

5Y-1.03%

3Y-1.93%

TTM11.99%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM173.93%

EPS CAGR

10Y-

5Y-

3Y-

TTM165.35%

ROCE

10Y Avg1.39%

5Y Avg0.86%

3Y Avg-0.33%

Latest-1.37%

Peer Comparison

Final Expense & Niche Life Providers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CIACitizens, Inc.	275.63M	5.48	18.90	1.8%	4.4%	4.82%	11.34%	0.04
AAMEAtlantic American Corporation	61.4M	3.01	-13.09	0.77%	2.45%	4.66%	7.45%	0.38

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	165.94M	166.08M	181.11M	185.55M	198.18M	195.35M	199.55M	187.85M	186.79M	188.23M
Revenue Growth %	-0%	0%	0.09%	0.02%	0.07%	-0.01%	0.02%	-0.06%	-0.01%	0.01%
Medical Costs & Claims+	144.6M	147.99M	160.96M	171.69M	184.7M	166.69M	179.19M	170.17M	168.62M	173.86M
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	21.34M	18.08M	20.15M	13.86M	13.48M	28.66M	20.36M	17.68M	18.17M	14.37M
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	0.11%	-0.15%	0.11%	-0.31%	-0.03%	1.13%	-0.29%	-0.13%	0.03%	-0.21%
Operating Expenses+	15.63M	14.56M	14.8M	14.83M	13.88M	13.16M	15.06M	15.59M	18.73M	19.63M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	1.12M	1.21M	1.44M	987K	996K	980K	1M	890K	652K	366K
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	5.71M	3.52M	5.36M	-971K	-407K	15.5M	5.3M	2.1M	-565K	-5.26M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	0.16%	-0.38%	0.52%	-1.18%	0.58%	39.09%	-0.66%	-0.6%	-1.27%	-8.32%
EBITDA+	6.83M	4.73M	6.79M	16K	589K	16.48M	6.3M	2.99M	87K	-4.9M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	1.43M	1.56M	1.72M	2.04M	2.13M	1.61M	1.39M	1.95M	3.27M	3.42M
Non-Operating Income	-1.43M	-1.56M	-1.72M	-2.04M	-2.13M	-1.61M	-1.39M	-1.95M	-3.27M	-3.42M
Pretax Income+	5.71M	3.52M	5.36M	-971K	-407K	15.5M	5.3M	2.1M	-565K	-5.26M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	1.32M	888K	828K	-267K	-21K	3.33M	1.02M	571K	-394K	-996K
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	4.39M	2.64M	4.53M	-704K	-386K	12.17M	4.28M	1.52M	-171K	-4.27M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.01%	-0.4%	0.72%	-1.16%	0.45%	32.53%	-0.65%	-0.64%	-1.11%	-23.96%
EPS (Diluted)+	0.19	0.11	0.20	-0.03	-0.02	0.56	0.19	0.06	-0.03	-0.23
EPS Growth %	0%	-0.42%	0.82%	-1.17%	0.45%	30.32%	-0.66%	-0.71%	-1.51%	-7.24%
EPS (Basic)	0.19	0.11	0.20	-0.03	-0.02	0.58	0.19	0.06	-0.03	-0.23
Diluted Shares Outstanding	23.09M	23.96M	22.64M	20.28M	20.26M	21.82M	20.4M	20.39M	20.4M	20.4M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	314.6M	318.6M	343.24M	344.27M	377.63M	405.19M	402.29M	367.06M	381.26M	393.43M
Asset Growth %	-0.01%	0.01%	0.08%	0%	0.1%	0.07%	-0.01%	-0.09%	0.04%	0.03%
Total Investment Assets+	229.69M	232.16M	239.7M	241.93M	489.1M	279.31M	542.33M	430.26M	237.07M	221.75M
Long-Term Investments	229.69M	232.16M	239.7M	232.38M	256.63M	274.06M	281.35M	221.53M	228.87M	221.75M
Short-Term Investments	0	0	0	210.39M	232.47M	254.11M	260.99M	208.73M	37.34M	0
Total Current Assets+	15.62M	13.25M	24.55M	12.63M	290.63M	0	328.11M	28.86M	0	35.57M
Cash & Equivalents	254.01M	257.43M	272.06M	12.63M	12.89M	19.32M	24.75M	28.86M	28.3M	35.57M
Receivables	0	0	0	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	26.03M	-330.02M	41.45M	-202M	-110.44M	-50.4M
Goodwill & Intangibles+	2.54M	2.54M	2.54M	2.54M	2.54M	2.54M	2.54M	2.54M	2.54M	2.54M
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	2.54M	2.54M	2.54M	2.54M	2.54M	0	2.54M	2.54M	0	2.54M
PP&E (Net)	-829K	-160K	-593K	-4.18M	258.86M	0	282.14M	3.4M	0	5.22M
Other Assets	-171.64M	-173.54M	-171.06M	-145.21M	-259.18M	-276.6M	-283.89M	-224.93M	-231.41M	-247.19M
Total Liabilities	212.11M	213.09M	230.26M	242.9M	259.23M	260.13M	261M	264.87M	273.99M	293.81M
Total Debt+	33.74M	33.74M	33.74M	33.74M	33.74M	33.74M	33.74M	35.75M	36.76M	37.76M
Net Debt	-220.27M	-223.69M	-238.32M	21.11M	20.84M	14.42M	8.98M	6.88M	8.46M	2.19M
Long-Term Debt	33.74M	33.74M	33.74M	33.74M	33.74M	33.74M	33.74M	35.75M	33.74M	33.74M
Short-Term Debt	0	0	0	0	0	0	1.03M	1.05M	3.02M	4.02M
Total Current Liabilities+	178.37M	179.36M	196.52M	209.16M	49.31M	0	1.75M	2.01M	0	4.02M
Accounts Payable	0	0	0	0	23.59M	0	25.46M	26.47M	0	0
Deferred Revenue	0	0	0	0	314K	0	0	-24.46M	0	0
Other Current Liabilities	-15.03M	-16.68M	-22.34M	-20.12M	25.41M	0	-24.74M	-1.05M	-3.02M	0
Deferred Taxes	-1000K	-1000K	593K	875K	1000K	1000K	1000K	919K	0	0
Other Liabilities	7.79M	9.71M	196.52M	0	0	-35.04M	-33.74M	229.12M	-33.74M	256.05M
Total Equity+	102.49M	105.51M	112.98M	101.37M	118.39M	145.06M	141.29M	102.19M	107.28M	99.61M
Equity Growth %	-0.02%	0.03%	0.07%	-0.1%	0.17%	0.23%	-0.03%	-0.28%	0.05%	-0.07%
Shareholders Equity	102.49M	105.51M	112.98M	101.37M	118.39M	145.06M	141.29M	102.19M	107.28M	99.61M
Minority Interest	0	0	0	0	0	0	0	0	0	0
Retained Earnings	25.44M	27.27M	30.99M	37.21M	36.02M	47.79M	51.26M	51.98M	50.93M	45.85M
Common Stock	22.4M	22.4M	22.4M	22.4M	22.4M	22.4M	22.4M	22.4M	22.4M	22.4M
Accumulated OCI	4.58M	5.83M	9.75M	-7.54M	10.46M	25M	17.69M	-22.15M	-16.12M	-18.71M
Return on Equity (ROE)	0.04%	0.03%	0.04%	-0.01%	-0%	0.09%	0.03%	0.01%	-0%	-0.04%
Return on Assets (ROA)	0.01%	0.01%	0.01%	-0%	-0%	0.03%	0.01%	0%	-0%	-0.01%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.33x	0.32x	0.30x	0.33x	0.28x	0.23x	0.24x	0.35x	0.34x	0.38x
Book Value per Share	4.44	4.40	4.99	5.00	5.84	6.65	6.93	5.01	5.26	4.88
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	2.21M	1.32M	2.63M	4.46M	-1.81M	8.97M	1.09M	6.45M	2.62M	4.8M
Operating CF Growth %	-0.5%	-0.4%	1%	0.69%	-1.41%	5.96%	-0.88%	4.93%	-0.59%	0.83%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	4.39M	2.64M	4.53M	-704K	-386K	12.17M	4.28M	1.52M	-171K	-4.27M
Depreciation & Amortization	1.12M	1.21M	1.44M	987K	996K	980K	1M	890K	652K	366K
Stock-Based Compensation	365K	586K	495K	244K	353K	437K	211K	134K	119K	11K
Deferred Taxes	304K	-2K	-1.36M	-2.24M	-913K	-2.25M	-1.11M	-1.82M	-3.12M	-1.75M
Other Non-Cash Items	-5.99M	-3.69M	-12.85M	3.15M	-13.48M	-2.81M	-7.01M	2.79M	-738K	54K
Working Capital Changes	2.02M	576K	10.38M	3.02M	11.62M	443K	3.72M	2.94M	5.88M	10.38M
Cash from Investing+	-1.2M	-2.23M	10.13M	-14.79M	3.01M	-2.06M	5.3M	-3.43M	-3.37M	2.28M
Capital Expenditures	-322K	-396K	-103K	-281K	-69K	-233K	-107K	-126K	-80K	-225K
Acquisitions	879K	1.84M	-10.23M	14.51M	0	1.83M	-5.41M	3.3M	0	0
Purchase of Investments	-91.68M	-75.07M	-84.55M	-49.55M	-124.03M	-27.49M	-35.29M	-17.01M	0	-13.85M
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0	1000K
Other Investing	-879K	-1.84M	10.23M	-14.51M	0	-1.83M	5.41M	-3.3M	-3.29M	0
Cash from Financing+	-1.76M	-1.45M	-1.47M	-1.59M	-939K	-481K	-954K	1.08M	181K	186K
Dividends Paid	-811K	-807K	-807K	-806K	-802K	-399K	-807K	-807K	-807K	-807K
Share Repurchases	-997K	-698K	-692K	-820K	-71K	-91K	-153K	-108K	-12K	-7K
Stock Issued	47K	51K	32K	36K	0	9K	6K	0	0	0
Debt Issuance (Net)	0	0	0	0	0	0	0	1000K	1000K	1000K
Other Financing	47K	51K	32K	36K	-66K	0	0	0	0	0
Net Change in Cash+	-753K	-2.37M	11.29M	-11.92M	263K	6.43M	5.43M	4.11M	-562K	7.27M
Exchange Rate Effect	0	0	0	0	0	0	0	0	0	0
Cash at Beginning	16.38M	15.62M	13.25M	24.55M	12.63M	12.89M	19.32M	24.75M	28.86M	28.3M
Cash at End	15.62M	13.25M	24.55M	12.63M	12.89M	19.32M	24.75M	28.86M	28.3M	35.57M
Free Cash Flow+	1.89M	920K	2.53M	4.18M	-1.88M	8.74M	981K	6.33M	2.54M	4.58M
FCF Growth %	4.79%	-0.51%	1.75%	0.65%	-1.45%	5.66%	-0.89%	5.45%	-0.6%	0.8%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	0.08	0.04	0.11	0.21	-0.09	0.4	0.05	0.31	0.12	0.22

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	96.56%	97.88%	97.04%	100.52%	100.21%	92.06%	97.34%	98.88%	100.3%	102.8%
Medical Cost Ratio	87.14%	89.11%	88.87%	92.53%	93.2%	85.33%	89.8%	90.59%	90.27%	92.37%
Return on Equity (ROE)	4.25%	2.53%	4.14%	-0.66%	-0.35%	9.24%	2.99%	1.25%	-0.16%	-4.13%
Return on Assets (ROA)	1.39%	0.83%	1.37%	-0.2%	-0.11%	3.11%	1.06%	0.4%	-0.05%	-1.1%
Equity / Assets	32.58%	33.12%	32.92%	29.45%	31.35%	35.8%	35.12%	27.84%	28.14%	25.32%
Book Value / Share	4.44	4.4	4.99	5	5.84	6.65	6.93	5.01	5.26	4.88
Debt / Equity	0.33x	0.32x	0.30x	0.33x	0.28x	0.23x	0.24x	0.35x	0.34x	0.38x
Revenue Growth	-0.23%	0.08%	9.05%	2.45%	6.8%	-1.43%	2.15%	-5.86%	-0.56%	0.77%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Bankers Fidelity	96.38M	99.7M	109.67M	119.12M	123.25M	121.17M	116.23M	115.16M	110.38M	111.04M
Bankers Fidelity Growth	-	3.44%	9.99%	8.62%	3.46%	-1.69%	-4.07%	-0.92%	-4.15%	0.60%
Corporate, Non-Segment	-	-	-	-	-	-	-	-	-	-
Corporate, Non-Segment Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
American Southern	54.51M	53.76M	53.66M	53.81M	58.68M	62.37M	67.98M	70.28M	68.44M	67.69M
American Southern Growth	-	-1.37%	-0.19%	0.27%	9.06%	6.29%	8.99%	3.37%	-2.61%	-1.10%

Frequently Asked Questions

Growth & Financials

Atlantic American Corporation (AAME) grew revenue by 0.8% over the past year. Growth has been modest.

Yes, Atlantic American Corporation (AAME) is profitable, generating $5.1M in net income for fiscal year 2024 (-2.3% net margin).

Dividend & Returns

Yes, Atlantic American Corporation (AAME) pays a dividend with a yield of 0.66%. This makes it attractive for income-focused investors.

Atlantic American Corporation (AAME) has a return on equity (ROE) of -4.1%. Negative ROE indicates the company is unprofitable.

Industry Metrics

Atlantic American Corporation (AAME) has a combined ratio of 102.8%. A ratio above 100% means claims and expenses exceed premiums.